True SpARKFuse103 FFPE OSU-TAS NA Negatives True SpARKFuse104 FFPE OSU-TAS NA Negatives True SpARKFuse105 FFPE OSU-TAS NA Negatives True SpARKFuse106 FFPE OSU-TAS NA Negatives True SpARKFuse107 FFPE OSU-TAS NA Negatives True SpARKFuse108 FFPE OSU-TAS NA Negatives True SpARKFuse109 FFPE OSU-TAS NA Negatives True SpARKFuse110 FFPE OSU-TAS NA Negatives Summary of 110 samples used for the analytic validation of OSU-SpARKFuse. Information regarding specimen type, source, and fusion involved genes for all samples are included. The status of each sample as determined during the validation is also indicated. OSU-TAS, Ohio State University Tissue Archive Service; OSU-13053, patient tissue derived under clinical research protocol; CMCL, Colorado Molecular Correlates Laboratory; NA, not applicable.
SpARKFuse103 FFPE OSU-TAS NA True Negatives SpARKFuse104 FFPE OSU-TAS NA True Negatives SpARKFuse105 FFPE OSU-TAS NA True Negatives SpARKFuse106 FFPE OSU-TAS NA True Negatives SpARKFuse107 FFPE OSU-TAS NA True Negatives SpARKFuse108 FFPE OSU-TAS NA True Negatives SpARKFuse109 FFPE OSU-TAS NA True Negatives SpARKFuse110 FFPE OSU-TAS NA True Negatives Summary of 110 samples used for the analytic validation of OSU-SpARKFuse. Information regarding specimen type, source, and fusion involved genes for all samples are included. The status of each sample as determined during the validation is also indicated. OSU-TAS, Ohio State University Tissue Archive Service; OSU-13053, patient tissue derived under clinical research protocol; CMCL, Colorado Molecular Correlates Laboratory; NA, not applicable.
1-s2.0-S1525157817301149-mmc4.docx